CERT1 and chlamydia trachomatis infectious disease: This interpretation is consistent with the result that (1R,3S)-HPA-12, which could be converted to PC-HPA-12 by chlamydial infection, showed a more potent anti-chlamydial activity than E16A, despite their comparable CERT inhibitory activities (Figure 6 and Figure 7D).